Nektar Therapeutics (NKTR)
1.34
+0.11
(+8.94%)
USD |
NASDAQ |
Nov 04, 16:00
1.335
0.00 (0.00%)
After-Hours: 20:00
Nektar Therapeutics Market Cap: 246.67M for Nov. 4, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 04, 2024 | 246.67M |
| November 01, 2024 | 226.42M |
| October 31, 2024 | 219.05M |
| October 30, 2024 | 230.10M |
| October 29, 2024 | 233.78M |
| October 28, 2024 | 250.35M |
| October 25, 2024 | 242.98M |
| October 24, 2024 | 248.51M |
| October 23, 2024 | 259.55M |
| October 22, 2024 | 265.07M |
| October 21, 2024 | 255.87M |
| October 18, 2024 | 259.55M |
| October 17, 2024 | 266.92M |
| October 16, 2024 | 254.03M |
| October 15, 2024 | 237.46M |
| October 14, 2024 | 242.98M |
| October 11, 2024 | 250.35M |
| October 10, 2024 | 237.46M |
| October 09, 2024 | 239.30M |
| October 08, 2024 | 239.30M |
| October 07, 2024 | 235.62M |
| October 04, 2024 | 242.98M |
| October 03, 2024 | 239.30M |
| October 02, 2024 | 244.83M |
| October 01, 2024 | 239.30M |
| Date | Value |
|---|---|
| September 30, 2024 | 239.30M |
| September 27, 2024 | 215.37M |
| September 26, 2024 | 204.33M |
| September 25, 2024 | 213.53M |
| September 24, 2024 | 222.74M |
| September 23, 2024 | 220.90M |
| September 20, 2024 | 239.30M |
| September 19, 2024 | 233.78M |
| September 18, 2024 | 231.94M |
| September 17, 2024 | 239.30M |
| September 16, 2024 | 233.78M |
| September 13, 2024 | 241.14M |
| September 12, 2024 | 230.10M |
| September 11, 2024 | 230.10M |
| September 10, 2024 | 228.26M |
| September 09, 2024 | 217.21M |
| September 06, 2024 | 206.17M |
| September 05, 2024 | 208.01M |
| September 04, 2024 | 228.26M |
| September 03, 2024 | 228.26M |
| August 30, 2024 | 235.62M |
| August 29, 2024 | 233.78M |
| August 28, 2024 | 231.94M |
| August 27, 2024 | 230.10M |
| August 26, 2024 | 250.35M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
80.64M
Minimum
Nov 28 2023
4.935B
Maximum
Jan 14 2020
1.732B
Average
865.24M
Median
Market Cap Benchmarks
| Eli Lilly and Co | 765.28B |
| Esperion Therapeutics Inc | 391.47M |
| NovaBay Pharmaceuticals Inc | 3.694M |
| Palatin Technologies Inc | 23.26M |
| iBio Inc | 22.98M |
Market Cap Related Metrics
| PS Ratio | 2.813 |
| Price to Book Value | 3.084 |
| Price | 1.34 |
| Earnings Yield | -67.42% |